Caplacizumab: frequent local skin reactions

Affiliations

• ¹ Department of Nephrology and Hypertension, Medical School Hannover, Hannover, Germany.
• ² Department II of Internal Medicine and Center for Molecular Medicine Cologne (CMMC), Faculty of Medicine and University Hospital Cologne, University of Cologne, Kerpener Str. 62, D-50937, Cologne, Germany. paul.brinkkoetter@uk-koeln.de.
• ³ Cologne Cluster of Excellence on Cellular Stress Responses in Ageing-Associated Diseases (CECAD), Cologne, Germany. paul.brinkkoetter@uk-koeln.de.
• ⁴ Charité - Universitätsmedizin Berlin, Department of Nephrology and Intensive Care Medicine, Berlin, Germany, and Experimental and Clinical Research Center, Charité, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.
• ⁵ Department of Nephrology, Vivantes Klinikum im Friedrichshain, Berlin, Germany.
• ⁶ Department of Cardiology and Nephrology, Helios Klinikum Berlin-Buch, Berlin, Germany.
• ⁷ Department of Nephrology, Helios Klinikum Krefeld, Krefeld, Germany.
• ⁸ Department of Nephrology and Hypertension, Medical School Hannover, Hannover, Germany. Jan.Menne@krh.de.
• ⁹ Department II of Internal Medicine and Center for Molecular Medicine Cologne (CMMC), Faculty of Medicine and University Hospital Cologne, University of Cologne, Kerpener Str. 62, D-50937, Cologne, Germany.
• ¹⁰ Cologne Cluster of Excellence on Cellular Stress Responses in Ageing-Associated Diseases (CECAD), Cologne, Germany.